Theragenics® Q1 Profit Spikes 104%
Published: May 10, 2012
The Buford, Ga.-based surgical products and cancer treatments company was unencumbered by charges in the first quarter of 2012 and its profit more than doubled.
Revenue: $21.6 million, up 7 percent
Net Income: $934,000, up 104 percent
Earnings Per Share: 3 cents, up 200 percent
M. Christine Jacobs, Theragenics chairman and CEO:
“In the first quarter we delivered revenue growth in both business segments and net earnings more than doubled. Cash flow from operations was strong and our balance sheet remains solid. To be sure, headwinds remain: macroeconomic uncertainties, unpredictable customer behavior, the looming medical device tax and CMS reimbursement policies, to name a few. Yet our prospects are brighter than last year.”